Device treatments for atrial fibrillation get so-so results in study

Medical device companies have invested millions of dollars into developing products to treat atrial fibrillation, an irregular heartbeat condition that are a frequent cause of strokes. But it's not clear how much good the products are doing. The Wall Street Journal reports on results of a new study on the procedure known as catheter ablation, which seeks to stop the faulty electrical signals that cause atrial fibrillation. The market for catheter ablation has grown to $4.5 billion worldwide. But…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Source Type: news